US Overactive Bladder Treatment Market development is benefiting from ongoing pharmaceutical research and innovation. Drug manufacturers are exploring improved therapies that aim to enhance treatment outcomes, tolerability, and patient adherence.
The overactive bladder treatment market was valued at US$ 4,295.93 million in 2021 and is expected to reach US$ 5,333.92 million by 2028, registering...